🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Shares

HealthEquity settles lawsuit for $30 million

Published 30/11/2024, 05:10 am
HQY
-

HealthEquity, Inc. (NASDAQ:HQY), a leader in health savings accounts with a market capitalization of $8.89 billion, has reached a settlement agreement over a lease termination lawsuit with Union Mesa 1, LLC. The agreement, disclosed in a recent 8-K filing with the Securities and Exchange Commission, was finalized on Wednesday. According to InvestingPro analysis, the company maintains a strong financial health score of "GREAT," with liquid assets exceeding short-term obligations by a factor of 4.1.

The dispute originated from the termination of a lease in April 2021, which had been a subject of ongoing litigation as previously reported in the company's financial disclosures. According to the terms of the settlement, Union Mesa will retain $2.8 million from a letter of credit it previously received. Additionally, HealthEquity and its subsidiary, WageWorks, Inc., will jointly pay Union Mesa $30.0 million.

In other recent news, HealthEquity reported strong financial growth and strategic expansions in its Q2 2025 results. The company experienced a 23% increase in revenue, a 46% rise in adjusted EBITDA, and a 27% growth in Health Savings Accounts (HSAs) assets. HealthEquity successfully completed the final part of the BenefitWallet acquisition, adding 216,000 HSAs and $1.0 billion in assets.

Goldman Sachs (NYSE:GS) initiated coverage on HealthEquity, assigning a Neutral rating and setting a price target of $108.00. The firm's analysis suggests a balanced perspective on the company's potential for earnings growth and its ability to meet long-term EPS targets. RBC Capital Markets adjusted its outlook on HealthEquity, increasing its price target to $100 and maintaining an Outperform rating.

KeyBanc maintained its Overweight rating on HealthEquity, with a steady price target of $100.00. The firm's analysis suggests that HealthEquity's stock is showing resilience in the early stages of a declining interest rate cycle. HealthEquity has also introduced Health Payment Accounts (HPAs) and announced a new $300 million share repurchase program.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.